14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GLYC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

GlycoMimetics stock price took a fall of -7.82% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 03, 2024 Loss -38.16% PDF

The GlycoMimetics stock price fell by -7.82% on the last day (Thursday, 25th Apr 2024) from $1.86 to $1.71. During the last trading day the stock fluctuated 6.81% from a day low at $1.70 to a day high of $1.81. The price has fallen in 7 of the last 10 days and is down by -31.74% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -110 thousand shares and in total, 546 thousand shares were bought and sold for approximately $933.85 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($2.02) are considered to be a "second chance" to get out. According to the fan-theory $1.22 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GLYC Signals & Forecast

There are few to no technical positive signals at the moment. The GlycoMimetics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.94 and $2.56. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -46.23%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for GlycoMimetics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.116 between high and low, or 6.81%. For the last week the stock has had daily average volatility of 10.84%.

GlycoMimetics is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLYC) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect GlycoMimetics to open at $1.74, and during the day (based on 14 day Average True Range), to move between $1.50 and $1.92, which gives a possible trading interval of +/-$0.213 (+/-12.43%) up or down from last closing price. If GlycoMimetics takes out the full calculated possible swing range there will be an estimated 24.86% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.80, some $0.0900 (5.26%) from the current price of $1.71, our system finds the risk reward not very attractive.

Earnings coming up

GlycoMimetics will release earnings BMO on Wednesday, May 01, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.150. We will update the financials statements for GlycoMimetics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.07% in the first trading day after earnings release.

Is GlycoMimetics stock A Buy?

GlycoMimetics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.583 Strong Sell Candidate Downgraded

Predicted Opening Price for GlycoMimetics of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.74 ( 1.67%) $1.71

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GLYC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.85 8.42 %
R2 1.81 5.84 %
R1 1.78 4.25 %
Current price: 1.71
Support S1 1.69 -0.91 %
S2 1.67 -2.51 %
S3 1.62 -5.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.93 12.57 %
R2 1.84 7.31 %
R1 1.80 5.26 %
Current price 1.71
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for GlycoMimetics Stock and on which exchange is it traded?
The symbol for GlycoMimetics is GLYC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell GlycoMimetics Stock?
GlycoMimetics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy GlycoMimetics Stock?
GlycoMimetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GlycoMimetics Stock.

What's the current price of GlycoMimetics Stock?
As of the end of day on the Apr 25, 2024, the price of an GlycoMimetics (GLYC) share was $1.71.

What is the 52-week high and low for GlycoMimetics Stock?
The 52-week high for GlycoMimetics Stock is $3.53 and the 52-week low is $1.11.

What is the market capitalization of GlycoMimetics Stock?
As of the Apr 25, 2024, the market capitalization of GlycoMimetics is 110.21M.

When is the next earnings date for GlycoMimetics?
The upcoming earnings date for GlycoMimetics is May 01, 2024.
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT